89
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Successful Treatment Of Notalgia Paresthetica With Lidocaine 5% Medicated Plaster: A Case Report

Pages 887-894 | Received 04 Jan 2022, Accepted 09 Sep 2022, Published online: 03 Oct 2022

References

  • Ansari A , WeinsteinD , SamiN. Notalgia paresthetica: treatment review and algorithmic approach. J. Dermatolog. Treat.31(4), 424–432 (2020).
  • Robbins BA , RayiA , Ferrer-BrukerSJ. Notalgia Paresthetica.StatPearls Publishing, FL, USA (2021).
  • Misery L , BrenautE , LeGarrec Ret al. Neuropathic pruritus. Nat. Rev. Neurol.10(7), 408–416 (2014).
  • Akram A . Notalgia paresthetica: cervical spine disease and neuropathic pruritus. Cureus13(1), e12975 (2021).
  • Howard M , SahharL , AndrewsF , BergmanR , GinD. Notalgia paresthetica: a review for dermatologists. Int. J. Dermatol.57(4), 388–392 (2018).
  • Andersen HH , AkiyamaT , NattkemperLAet al. Alloknesis and hyperknesis-mechanisms, assessment methodology, and clinical implications of itch sensitization. Pain159(7), 1185–1197 (2018).
  • Lipman ZM , MagnoloN , GolpanianRS , StorckM , YosipovichG , ZeidlerC. Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: a retrospective analysis from 2 itch centers. JAAD Int.2, 96–97 (2020).
  • Andersen HH , SandC , ElberlingJ. Considerable variability in the efficacy of 8% capsaicin topical patches in the treatment of chronic pruritus in 3 patients with notalgia paresthetica. Ann. Dermatol.28(1), 86–89 (2016).
  • Akram A . Notalgia paresthetica: cervical spine disease and neuropathic pruritus. Cureus13(1), e12975 (2021).
  • Binder A , KoroschetzJ , BaronR. Disease mechanisms in neuropathic itch. Nat. Clin. Pract. Neurol.4(6), 329–337 (2008).
  • Steinhoff M , SchmelzM , SzabóIL , OaklanderAL. Clinical presentation, management, and pathophysiology of neuropathic itch. Lancet Neurol.17(8), 709–720 (2018).
  • Pereira MP , WiegmannH , AgelopoulosK , StänderS. Neuropathic Itch: Routes to Clinical Diagnosis. Front Med (Lausanne)24(8), 641746 (2021).
  • Potenzieri C , UndemBJ. Basic mechanisms of itch. Clin. Exp. Allergy42(1), 8–19 (2012).
  • Stumpf A , StänderS. Neuropathic itch: diagnosis and management. Dermatol. Ther.26(2), 104–109 (2013).
  • Perez C , GalvezR , HuelbesSet al. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 Questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual. Life Outcomes5, 66 (2007).
  • Oaklander AL . Common neuropathic itch syndromes. Acta Derm. Venereol.92(2), 118–125 (2012).
  • Savk E , SavkO , BolukbasiOet al. Notalgia paresthetica: a study on pathogenesis. Int. J. Dermatol.39(10), 754–759 (2000).
  • da Cruz CM , AntunesF. Physical medicine and rehabilitation role on notalgia paresthetica: case report and treatment review. Am. J. Phys. Med. Rehabil.97(12), 929–932 (2018).
  • Chtompel Y , EghtesadiM , Vargas-SchafferG. A case report of refractory notalgia paresthetica treated with lidocaine infusions. Am. J. Case Rep.18, 1225–1228 (2017).
  • Patel P , PatelK , PandherK , TareenRS. The role of psychiatric, analgesic, and antiepileptic medications in chronic pruritus. Cureus13(8), e17260 (2021).
  • Maciel AA , CunhaPR , LaraiaIO , TrevisanF. Efficacy of gabapentin in the improvement of pruritus and quality of life of patients with notalgia paresthetica. An. Bras. Dermatol.89(4), 570–575 (2014).
  • Kaur R , SinhaVR. Antidepressants as antipruritic agents: a review. Eur. Neuropsychopharmacol.28(3), 341–352 (2018).
  • Savk E , SavkO , SendurF. Transcutaneous electrical nerve stimulation offers partial relief in notalgia paresthetica patients with a relevant spinal pathology. J. Dermatol.34(5), 315–319 (2007).
  • Morcillo Pérez C , GuerrasNormand I , GarcíaChinchetru MC. Notalgiaparestésica, tratamiento con toxina botulínica tipo A [Notalgia paresthetica: treatment with botulinum toxin type A]. Rehabilitacion (Madr.)54(2), 142–145 (2020).
  • Pérez-Pérez L , García-GavínJ , AllegueF , CaeiroJL , FabeiroJM , ZulaicaA. Notalgia paresthetica: treatment using intradermal botulinum toxin A. Actas Dermosifiliogr.105(1), 74–77 (2014).
  • Cohen PR . Notalgia paresthetica: a novel approach to treatment with cryolipolysis. Cureus9(9), e1719 (2017).
  • Morin CB , RaefHS , ElmariahSB. Neuropathic itch treated with oral cannabinoids: a case series. JAAD Case Rep.17, 38–42 (2021).
  • Savk E , BolukbasiO , AkyolA , KaramanG. Open pilot study on oxcarbazepine for the treatment of notalgia paresthetica. J. Am. Acad. Dermatol.45(4), 630–632 (2001).
  • Mülkoğlu C , NacırB. Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option. BMC Neurol.20(1), 191 (2020).
  • Pickering G , MartinE , TiberghienF , DelormeC , MickG. Localized neuropathic pain: an expert consensus on local treatments. Drug Des. Devel. Ther.11, 2709–2718 (2017).
  • Pickering G , LucchiniC. Topical treatment of localized neuropathic pain in the elderly. Drugs Aging37(2), 83–89 (2020).
  • Finnerup NB , AttalN , HaroutounianSet al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol.14(2), 162–173 (2015).
  • Sawynok J . Topical analgesics for neuropathic pain in the elderly: current and future prospects. Drugs Aging31(12), 853–862 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.